Tailoring cardiac environment in microphysiological systems: an outlook on current and perspective heart-on-chip platforms.
作者信息
Ugolini Giovanni Stefano, Visone Roberta, Cruz-Moreira Daniela, Redaelli Alberto, Rasponi Marco
机构信息
Department of Electronics, Information & Bioengineering, Politecnico di Milano, Milan, Italy.
出版信息
Future Sci OA. 2017 May 3;3(2):FSO191. doi: 10.4155/fsoa-2017-0024. eCollection 2017 Jun.
Abstract
摘要
相似文献
1
Tailoring cardiac environment in microphysiological systems: an outlook on current and perspective heart-on-chip platforms.在微生理系统中定制心脏环境：当前及未来心脏芯片平台展望
Future Sci OA. 2017 May 3;3(2):FSO191. doi: 10.4155/fsoa-2017-0024. eCollection 2017 Jun.
2
Generation of functional cardiac microtissues in a beating heart-on-a-chip.在跳动的心脏芯片上生成功能性心脏微组织。
Methods Cell Biol. 2018;146:69-84. doi: 10.1016/bs.mcb.2018.05.005. Epub 2018 Jul 9.
3
Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.更广泛采用肝脏及相互连接的微生理系统所面临的机遇与挑战。
Exp Biol Med (Maywood). 2017 Oct;242(16):1593-1604. doi: 10.1177/1535370217708976. Epub 2017 May 15.
4
Microphysiological Systems (Tissue Chips) and their Utility for Rare Disease Research.微生理系统（组织芯片）及其在罕见病研究中的应用。
Adv Exp Med Biol. 2017;1031:405-415. doi: 10.1007/978-3-319-67144-4_23.
5
The ascendance of microphysiological systems to solve the drug testing dilemma.微生理系统的崛起以解决药物测试困境。
Future Sci OA. 2017 Mar 31;3(2):FSO185. doi: 10.4155/fsoa-2017-0002. eCollection 2017 Jun.
6
Microphysiological systems: analysis of the current status, challenges and commercial future.微生理系统：现状、挑战及商业前景分析
Microphysiol Syst. 2018 Nov 5;2. doi: 10.21037/mps.2018.10.01. eCollection 2018 Nov 1.
7
Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.将组织芯片和微生理系统融入医学、生物学、药理学和毒理学的整体框架之中。
Exp Biol Med (Maywood). 2017 Oct;242(16):1559-1572. doi: 10.1177/1535370217732765.
8
Facilitating the commercialization and use of organ platforms generated by the microphysiological systems (Tissue Chip) program through public-private partnerships.通过公私合作促进微生理系统（组织芯片）项目所产生的器官平台的商业化及应用。
Comput Struct Biotechnol J. 2016 May 10;14:207-210. doi: 10.1016/j.csbj.2016.04.003. eCollection 2016.
9
A microscale biomimetic platform for generation and electro-mechanical stimulation of 3D cardiac microtissues.一种用于生成和机电刺激三维心脏微组织的微观仿生平台。
APL Bioeng. 2018 Oct 29;2(4):046102. doi: 10.1063/1.5037968. eCollection 2018 Dec.
10
Kidney-on-a-Chip: A New Technology for Predicting Drug Efficacy, Interactions, and Drug-induced Nephrotoxicity.芯片肾脏：预测药物疗效、相互作用及药物性肾毒性的新技术。
Curr Drug Metab. 2018;19(7):577-583. doi: 10.2174/1389200219666180309101844.
引用本文的文献
1
Assessing the influence of perfusion on cardiac microtissue maturation: A heart-on-chip platform embedding peristaltic pump capabilities.评估灌注对心脏微组织成熟的影响：一种嵌入蠕动泵功能的心脏芯片平台。
Biotechnol Bioeng. 2021 Aug;118(8):3128-3137. doi: 10.1002/bit.27836. Epub 2021 Jun 1.
2
Scalable Biomimetic Coaxial Aligned Nanofiber Cardiac Patch: A Potential Model for "Clinical Trials in a Dish".可扩展的仿生同轴排列纳米纤维心脏贴片：“盘中临床试验”的潜在模型
Front Bioeng Biotechnol. 2020 Sep 16;8:567842. doi: 10.3389/fbioe.2020.567842. eCollection 2020.
3
Looking to the future of organs-on-chip.展望器官芯片的未来。
Future Sci OA. 2017 May 26;3(2):FSO205. doi: 10.4155/fsoa-2017-0040. eCollection 2017 Jun.
本文引用的文献
1
Microfabricated Physiological Models for In Vitro Drug Screening Applications.用于体外药物筛选应用的微制造生理模型
Micromachines (Basel). 2016 Dec 15;7(12):233. doi: 10.3390/mi7120233.
2
Human cardiac fibroblasts adaptive responses to controlled combined mechanical strain and oxygen changes in vitro.人心脏成纤维细胞在体外对可控的联合机械应变和氧气变化的适应性反应。
Elife. 2017 Mar 18;6:e22847. doi: 10.7554/eLife.22847.
3
Instrumented cardiac microphysiological devices via multimaterial three-dimensional printing.基于多材料三维打印的仪器化心脏微生理装置
Nat Mater. 2017 Mar;16(3):303-308. doi: 10.1038/nmat4782. Epub 2016 Oct 24.
4
Cardiac Meets Skeletal: What's New in Microfluidic Models for Muscle Tissue Engineering.心脏与骨骼的交汇：肌肉组织工程微流控模型的新进展
Molecules. 2016 Aug 26;21(9):1128. doi: 10.3390/molecules21091128.
5
Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses.用于生理相关药物反应分析的小型化诱导多能干细胞衍生心肌
Sci Rep. 2016 Apr 20;6:24726. doi: 10.1038/srep24726.
6
Beating heart on a chip: a novel microfluidic platform to generate functional 3D cardiac microtissues.芯片上的跳动心脏：一种用于生成功能性三维心脏微组织的新型微流控平台。
Lab Chip. 2016 Feb 7;16(3):599-610. doi: 10.1039/c5lc01356a.
7
A Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte (hiPSC-CM) Multielectrode Array Assay for Preclinical Cardiac Electrophysiology Safety Screening.一种用于临床前心脏电生理学安全筛查的人诱导多能干细胞衍生心肌细胞（hiPSC-CM）多电极阵列检测方法。
Curr Protoc Pharmacol. 2015 Dec 8;71:11.18.1-11.18.15. doi: 10.1002/0471141755.ph1118s71.
8
On-chip assessment of human primary cardiac fibroblasts proliferative responses to uniaxial cyclic mechanical strain.人原代心脏成纤维细胞对单轴循环机械应变增殖反应的芯片上评估
Biotechnol Bioeng. 2016 Apr;113(4):859-69. doi: 10.1002/bit.25847. Epub 2015 Oct 26.
9
Controlled electromechanical cell stimulation on-a-chip.芯片上的可控机电细胞刺激
Sci Rep. 2015 Jul 2;5:11800. doi: 10.1038/srep11800.
10
A non-invasive platform for functional characterization of stem-cell-derived cardiomyocytes with applications in cardiotoxicity testing.一种用于干细胞来源的心肌细胞功能特征分析的非侵入性平台，可应用于心脏毒性测试。
Stem Cell Reports. 2015 Apr 14;4(4):621-31. doi: 10.1016/j.stemcr.2015.02.007. Epub 2015 Mar 19.
Zotero 插件